Search

everythinglearnresearchcommunity

for

Search:↓

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Human hair follicle stem cells improve ovarian function in mice with damaged ovaries.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Increased ODC activity leads to skin tumors by recruiting stem cells, not by toxic byproducts.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

A cancer patient's hair became permanently curly after treatment with nivolumab.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

PRC2 is essential for maintaining intestinal cell balance and aiding regeneration after damage.

Platelet-rich plasma helps protect and improve ovarian function in rats treated with cyclophosphamide.

Paxillin may help manage androgen-related disorders like PCOS by stabilizing androgen receptor proteins.

Geranyl acetate can protect skin cells from damage and inflammation caused by para-phenylenediamine.

Procyanidin B2 and leucopelargonidin from Saraca asoca may help treat PCOS by balancing hormones.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Ritlecitinib is safe and may effectively treat alopecia areata.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.